Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sepideh Kalhor & Alireza Fattahi. (2022) In silico design of novel anticancer drugs with amino acid and carbohydrate building blocks to inhibit PIM kinases. Molecular Simulation 48:6, pages 526-540.
Read now
Read now
Sidhant Jain & Sahil Kumar. (2020) Cancer immunotherapy: dawn of the death of cancer?. International Reviews of Immunology 39:5, pages 205-222.
Read now
Read now
Cristina M Quintella, Heitor M Quintella, Mayla Rohweder & Guilherme M Quintella. (2020) Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association. Expert Opinion on Therapeutic Patents 30:4, pages 287-301.
Read now
Read now
Zoila A. Lopez-Bujanda, Matthew G. Chaimowitz, Todd D. Armstrong, Jeremy B. Foote, Leisha A. Emens & Charles G. Drake. (2020) Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. OncoImmunology 9:1.
Read now
Read now
Liran Levy, Inbal Mishalian, Rachel Bayuch, Lida Zolotarov, Janna Michaeli & Zvi G Fridlender. (2015) Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response. OncoImmunology 4:4.
Read now
Read now
Elizabeth A Mittendorf, Gheath Alatrash, Haile Xiao, G Travis Clifton, James L Murray & George E Peoples. (2011) Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Review of Vaccines 10:6, pages 755-774.
Read now
Read now
Heloisa P Soares & Jose Lutzky. (2010) Velimogene aliplasmid. Expert Opinion on Biological Therapy 10:5, pages 841-851.
Read now
Read now
Articles from other publishers (45)
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, Summya Rashid, Muhammad Omer Iqbal, Renata Kontek, Muhanad A. Abdulsamad & Abdulmutalib A. Allaq. (2023) Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. Cancers 15:10, pages 2721.
Crossref
Crossref
Hossein Javid, Alireza Sharbaf Mashhad, Shaghayegh Yazdani, Mahsa Akbari Oryani, Sanaz Akbari, Nastaran Rezagholinejad, Mahboubeh Tajaldini & Mehdi Karimi‐Shahri. (2023) The role of viruses in cancer development versus cancer therapy: An oncological perspective. Cancer Medicine 12:10, pages 11127-11148.
Crossref
Crossref
Luis Mejías Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, Pablo Sala, Belén P. Solans, Laura Hato, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Guillén-Grima, Jaime Espinós, Susana De La Cruz, María Dolores Lozano, Miguel A Idoate & Marta Santisteban. (2023) Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines 11:2, pages 238.
Crossref
Crossref
Hoorieh Soleimanjahi & Seyed-Mahmood Seyed-Khorrami. 2023. Cancer Nanotechnology. Cancer Nanotechnology
229
252
.
Atefeh Arab, Amin Reza Nikpoor, Peyman Asadi, Reza Iraei, Rezvan Yazdian-Robati, Afsana Sheikh & Prashant Kesharwani. (2022) Virus-like nanoparticles (VLPs) based technology in the development of breast cancer vaccines. Process Biochemistry 123, pages 44-51.
Crossref
Crossref
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, Saman Sargazi, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. Journal of Controlled Release 349, pages 844-875.
Crossref
Crossref
María Lilia Nicolás-Morales, Arianna Luisa-Sanjuan, Mayralina Gutiérrez-Torres, Amalia Vences-Velázquez, Carlos Ortuño-Pineda, Mónica Espinoza-Rojo, Napoleón Navarro-Tito & Karen Cortés-Sarabia. (2022) Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. Vaccines 10:8, pages 1249.
Crossref
Crossref
Wenyu Cao, Xinyue Ma, Jean Victoria Fischer, Chenggong Sun, Beihua Kong & Qing Zhang. (2021) Immunotherapy in endometrial cancer: rationale, practice and perspectives. Biomarker Research 9:1.
Crossref
Crossref
Sibapriya Chaudhuri, Scott Thomas & Pamela Munster. (2021) Immunotherapy in breast cancer: A clinician's perspective. Journal of the National Cancer Center 1:2, pages 47-57.
Crossref
Crossref
Juan Carlos Chimal-Eguia, Erandi Castillo-Montiel, Julio Cesar Rangel-Reyes & Ricardo Teodoro Paez-Hernández. (2021) Modeling Dendritic Cell Pulsed Immunotherapy for Mice with Melanoma—Protocols for Success and Recurrence. Applied Sciences 11:7, pages 3199.
Crossref
Crossref
Pui Yan Siak, Kuan Yee Wong, Adelene Ai-Lian Song, Raha Abdul Rahim & Lionel Lian Aun In. (2021) K-Ras Peptide Mimotope Induces Antigen Specific Th1 and B-Cell Immune Responses against G12A-Mutated K-Ras Antigen in Balb/c Mice. Vaccines 9:3, pages 195.
Crossref
Crossref
Iago Dillion Lima Cavalcanti & José Cleberson Santos SoaresIago Dillion Lima Cavalcanti & José Cleberson Santos Soares. 2021. Advances in Cancer Treatment. Advances in Cancer Treatment
57
78
.
Amir Atapour, Manica Negahdaripour, Younes Ghasemi, Dorna Razmjuee, Amir Savardashtaki, Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Ali Aliabadi & Navid Nezafat. (2019) In Silico Designing a Candidate Vaccine Against Breast Cancer. International Journal of Peptide Research and Therapeutics 26:1, pages 369-380.
Crossref
Crossref
Emad I. Wafa, Sean M. Geary, Kathleen A. Ross, Jonathan T. Goodman, Balaji Narasimhan & Aliasger K. Salem. (2019) Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine. Nanomedicine: Nanotechnology, Biology and Medicine 21, pages 102055.
Crossref
Crossref
C. Leduc & E. Quoix. (2019) Les thérapies vaccinales dans le cancer bronchique. Revue des Maladies Respiratoires 36:3, pages 415-425.
Crossref
Crossref
Neda Yaghoubi, Arash Soltani, Kiarash Ghazvini, Seyed Mahdi Hassanian & Seyed Isaac Hashemy. (2019) PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer. Biomedicine & Pharmacotherapy 110, pages 312-318.
Crossref
Crossref
Leon ChenAlexander B. AriaSirunya SilapuntMichael R. Migden. (2019) Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer. Dermatologic Surgery 45:1, pages 1-16.
Crossref
Crossref
Sepideh Parvizpour, Jafar Razmara & Yadollah Omidi. (2018) Breast cancer vaccination comes to age: impacts of bioinformatics. BioImpacts 8:3, pages 223-235.
Crossref
Crossref
Gretchen Bergado Báez, Diana R. Hernández Fernández, Zaima Mazorra Herrera & Belinda Sánchez Ramírez. (2018) HER1-based vaccine: Simultaneous activation of humoral and cellular immune response. Seminars in Oncology 45:1-2, pages 75-83.
Crossref
Crossref
Tim F. Greten & Bruno Sangro. (2018) Targets for immunotherapy of liver cancer. Journal of Hepatology 68:1, pages 157-166.
Crossref
Crossref
Guangzu Zhao, Saranya Chandrudu, Mariusz Skwarczynski & Istvan Toth. (2017) The application of self-assembled nanostructures in peptide-based subunit vaccine development. European Polymer Journal 93, pages 670-681.
Crossref
Crossref
Anand Khandoobhai, Ming Poi, Katherine Kelley, Jay Mirtallo, Ben Lopez & Niesha Griffith. (2017) National survey of comprehensive pharmacy services provided in cancer clinical trials. American Journal of Health-System Pharmacy 74:11_Supplement_2, pages S35-S41.
Crossref
Crossref
Qiaohong Wang & Xia Wu. (2017) Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment. International Immunopharmacology 46, pages 210-219.
Crossref
Crossref
Jinqiu Chen, Miling Zhang, Fuling Zhou, Jin Wang, Ben Niu & Wanggang Zhang. (2017) Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model. Oncology Letters 13:4, pages 2323-2329.
Crossref
Crossref
Jake S. O'Donnell, Georgina V. Long, Richard A. Scolyer, Michele W.L. Teng & Mark J. Smyth. (2017) Resistance to PD1/PDL1 checkpoint inhibition. Cancer Treatment Reviews 52, pages 71-81.
Crossref
Crossref
J.R. Yannelli, R. Wouda, T.J. Masterson, M.G. Avdiushko & D.A. Cohen. (2016) Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs. Veterinary Immunology and Immunopathology 182, pages 95-100.
Crossref
Crossref
Sudheer Gupta, Kumardeep Chaudhary, Sandeep Kumar Dhanda, Rahul Kumar, Shailesh Kumar, Manika Sehgal, Gandharva Nagpal & Gajendra P. S. Raghava. (2016) A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer. PLOS ONE 11:11, pages e0166372.
Crossref
Crossref
Gourav Dhiman, Neha Lohia, Sahil Jain & Manoj Baranwal. (2016)
Metadherin peptides containing CD4
+
and CD8
+
T cell epitopes as a therapeutic vaccine candidate against cancer
. Microbiology and Immunology 60:9, pages 646-652.
Crossref
Crossref
Sharan Bobbala & Sarah Hook. (2016) Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?. Pharmaceutical Research 33:9, pages 2078-2097.
Crossref
Crossref
Federico Frascoli, Emelie Flood & Peter S. Kim. (2016) A model of the effects of cancer cell motility and cellular adhesion properties on tumour-immune dynamics. Mathematical Medicine and Biology, pages dqw004.
Crossref
Crossref
Steven A. Limentani, Mario Campone, Thierry Dorval, Giuseppe Curigliano, Richard de Boer, Charles Vogel, Shane White, Thomas Bachelot, Jean-Luc Canon, Mary Disis, Ahmad Awada, Martine Berlière, Frédéric Amant, Ellis Levine, Wivine Burny, Andrea Callegaro, Pedro Miguel de Sousa Alves, Jamila Louahed, Vincent Brichard & Frédéric F. Lehmann. (2016) A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors. Breast Cancer Research and Treatment 156:2, pages 319-330.
Crossref
Crossref
Alejandrina Vendrell, Claudia Mongini, María José Gravisaco, Andrea Canellada, Agustina Inés Tesone, Juan Carlos Goin & Claudia Inés Waldner. (2016) An Oral Salmonella-Based Vaccine Inhibits Liver Metastases by Promoting Tumor-Specific T-Cell-Mediated Immunity in Celiac and Portal Lymph Nodes: A Preclinical Study. Frontiers in Immunology 7.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
561
593
.
Isaac Nahon-Serfaty. (2013) Vaccins et communication : La convergence comme stratégie de création de valeur socialeVaccines and communication: Convergence as a strategy for the creation of social value. Communiquer. Revue de communication sociale et publique:8, pages 1-12.
Crossref
Crossref
Boris KubuschokMichael PfreundschuhRainer BreitFrank HartmannMartina SesterBarbara GärtnerJochem KönigNiels MurawskiGerhard HeldCarsten ZwickFrank Neumann. (2012) Mutated Ras-Transfected, EBV-Transformed Lymphoblastoid Cell Lines as a Model Tumor Vaccine for Boosting T-Cell Responses Against Pancreatic Cancer: A Pilot Trial. Human Gene Therapy 23:12, pages 1224-1236.
Crossref
Crossref
Xianming Huang, Dan Ye & Philip E. Thorpe. (2011) Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine. Vaccine 29:29-30, pages 4785-4793.
Crossref
Crossref
Mladen Korbelik. (2020) Cancer vaccines generated by photodynamic therapy. Photochemical & Photobiological Sciences 10:5, pages 664-669.
Crossref
Crossref
Jessica A. Miller, Patricia A. Thompson, Iman A. Hakim, H.-H. Sherry Chow & Cynthia A. Thomson. (2010) d-Limonene: a bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment. Oncology Reviews 5:1, pages 31-42.
Crossref
Crossref
Robert O. Dillman. (2011) Cancer Immunotherapy. Cancer Biotherapy and Radiopharmaceuticals 26:1, pages 1-64.
Crossref
Crossref
Teresa Gilewski. (2010) Targeting the Immune System as a Therapeutic Strategy for Patients with Breast Cancer. Current Breast Cancer Reports 2:4, pages 214-221.
Crossref
Crossref
Zvi G. Fridlender, George Buchlis, Veena Kapoor, Guanjun Cheng, Jing Sun, Sunil Singhal, M. Cecilia Crisanti, Liang-Chuan S. Wang, Daniel Heitjan, Linda A. Snyder & Steven M. Albelda. (2010) CCL2 Blockade Augments Cancer Immunotherapy. Cancer Research 70:1, pages 109-118.
Crossref
Crossref
Simon J. Draper & Jonathan L. Heeney. (2009) Viruses as vaccine vectors for infectious diseases and cancer. Nature Reviews Microbiology 8:1, pages 62-73.
Crossref
Crossref
James W. Hodge, Jack Higgins & Jeffrey Schlom. (2009) Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen. Vaccine 27:33, pages 4475-4482.
Crossref
Crossref
John R. Yannelli. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy
505
526
.
Gunnar Myhr. (2008) Multimodal Cancer Treatment: Real Time Monitoring, Optimization, and Synergistic Effects. Technology in Cancer Research & Treatment 7:5, pages 409-414.
Crossref
Crossref